Jean-Philippe Combal, CEO of Vivet Therapeutics, will be talking about "Investigating Novel Vector Technology with the Promise of Enhancing the Efficacy of Gene Therapy" at the Gene Therapy for Rare Disorders Europe conference in London on Nov. 1st at 11.30am.